Kristin Schuhwerk

Ms. Schuhwerk joined Scorpion Therapeutics in October 2021 as Chief Operating Officer, bringing nearly three decades of drug development experience across multiple therapeutic areas to the company. In this role, she is responsible for overseeing all day-to-day operations including portfolio management, clinical operations, manufacturing and facilities. 

Ms. Schuhwerk’s professional experience spans the healthcare ecosystem including pharmaceutical, biotechnology, CRO and academic organizations. In each of her roles, she has helped to define the organizational strategy and oversee its execution, leading to a rapid expansion of responsibilities.

Prior to joining Scorpion, Ms. Schuhwerk served as Global Head of Project & Portfolio Management for Development at Sanofi S.A. (“Sanofi”) between 2018 and 2021. During this time, she had oversight of all products in Development.  Prior to that she oversaw worldwide Clinical Operations, managing 300+ clinical trials across all therapeutic areas for the company. Ms. Schuhwerk was also the recipient of the 2021 HBA luminary award that recognized her as a role model leader and mentor.

Ms. Schuhwerk holds a B.S. degree in Chemistry from the University of New Hampshire.